Table 1.

Health history, baseline medications and ethnicity of the study participants after randomization.

		MICT+RT (n = 11)	HIIT+RT (n = 12)	P-value
Health history	Personal history of MI	2 (18.2%)	2 (16.7%)	0.99
	History of stroke	0	0	NC
	History of TIA	1 (9.1%)	0	NC
	History of AO	0	0	NC
	History of PAD	0	0	NC
	Ex-Smokers (>2 years)	5 (45.5%)	5 (41.7%)	0.86
	Smoking (currently)	0	0	NC
	Family history of MI	6 (54.6%)	5 (41.7%)	0.54
	Atrial fibrillation	0	1 (8.3%)	NC
	Neuropathic pain	0	0	NC
	Mild retinopathy	1 (9.1%)	1 (8.3%)	0.99
	OSA requiring CPAP	3 (27.3%)	2 (16.7%)	0.64
	Arthritis	1 (9.1%)	1 (8.3%)	0.99
	Gout	2 (18.2%)	0	NC
	Total hip replacement	1 (9.1%)	0	NC
MEDICATIONS
Antihyperglycaemia	Biguanide (Metformin)	9 (81.8%)	12 (100%)	NC
	Sulfonylureas	5 (45.5%)	3 (25.0%)	0.40
	Exogenous Insulin	4 (36.4%)	5 (41.7%)	0.99
Hypertension	ACE Inhibitors	4 (36.4%)	10 (83.3%)	0.04
	Non ACE Inhibitors	7 (63.6%)	2 (16.7%)	0.04
	Beta Blockers	3 (27.3%)	2 (16.7%)	0.64
	Diuretic	0	2 (16.7%)	NC
Other Cardiac	Statins	5 (45.5%)	9 (75.0%)	0.40
	Anticoagulants	5 (45.5%)	6 (50.0%)	0.83
Respiratory	Bronchodilators	1 (9.1%)	2 (16.7%)	0.99
	Antihistamines	0	2 (16.7%)	NC
	Reflux	1 (9.1%)	0	NC
Other	Anti-depressants	2 (18.2%)	3 (25.0%)	0.99
	Gout	2 (18.2%)	0	NC
	Erectile dysfunction	0	1 (8.3%)	NC
	NSAID	0	1 (8.3%)	NC
	Analgesics	0	1 (8.3%)	NC
Ethnicity	European	9 (81.8%)	9 (75.0%)	0.99
	Māori	1 (9.1%)	2 (16.7%)	0.99
	Asian	1 (9.1%)	1 (8.3%)	0.99

Data are number of participants (percentage).

ACE, angiotensin converting enzyme; AO, arteriosclerosis obliterans; CPAP, continuous positive airway pressure; HIIT, high-intensity interval training; MI, myocardial infarction; MICT, moderate-intensity continuous training; NC, not calculable; NSAID, non-steroidal anti-inflammatory drug; OSA, obstructive sleep apnoea; PAD, peripheral artery disease; TIA, transient ischaemic attack.